The Inventurus Knowledge Solutions (IKS) IPO has opened for subscription, running from December 12 to December 16, 2024. This much-anticipated public offering aims to raise approximately ₹2,497.92 crore and consists of a fresh issue component along with an offer-for-sale (OFS) of up to 1.87 crore equity shares, each with a face value of ₹1. With backing from prominent investor Rekha Jhunjhunwala, the IPO has generated significant interest among investors.

Understanding the IKS IPO GMP

One of the key indicators of the IPO’s potential success is its grey market premium (GMP), which currently stands at ₹405 per share. This suggests an estimated listing price of ₹1,734 per share, translating to a potential gain of 30.47% over the upper price band of ₹1,329. The strong GMP reflects positive investor sentiment and confidence in the company’s future performance, bolstered by Jhunjhunwala’s reputation in the market.

Subscription Status

The subscription figures for the IKS IPO indicate a robust response from various investor categories. The Retail Individual Investors (RIIs) segment was subscribed 4.24 times, showcasing strong interest from retail investors. The non-institutional investors (NII) category also saw a healthy subscription rate of 3.13 times, while Qualified Institutional Buyers (QIBs) exhibited notable interest with a subscription rate of 1.89 times. These figures highlight the broad appeal of the IPO across different investor segments.

IPO Details

The Inventurus Knowledge Solutions IPO is priced within a band of ₹1,265 to ₹1,329 per share. The allocation structure is designed to cater to a diverse range of investors, with 75% of the shares reserved for QIBs, 15% for High Net-Worth Individuals (HNIs), and 10% for retail investors. Following the allotment process, shares are set to list on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on December 19, 2024. The allotments will be finalized by December 17.

About Inventurus Knowledge Solutions

Founded in 2006, Inventurus Knowledge Solutions Limited (IKS Health) specializes in providing healthcare technology solutions aimed at streamlining administrative processes for healthcare providers. The company focuses on medical documentation management, virtual medical scribing, and clinical support, significantly reducing the administrative burden on healthcare professionals. This focus on efficiency and innovation positions IKS Health as a valuable player in the healthcare technology sector.

The company has demonstrated impressive financial growth, with revenue surging to ₹1,817.93 crore in FY 2024, up from ₹1,031.30 crore in FY 2023. Similarly, net profit increased from ₹305.23 crore in FY 2023 to ₹370.49 crore in FY 2024, showcasing the company’s strong operational performance and growth trajectory.

Promoter Group

The promoter group of IKS includes notable names such as Sachin Gupta, Rekha Jhunjhunwala, and various discretionary trusts associated with the Jhunjhunwala family. Rekha Jhunjhunwala’s backing adds significant credibility to the IPO, as she is a well-respected figure in the investment community known for her successful track record.

Conclusion

The IKS IPO is generating considerable excitement in the market, with strong subscription figures and a promising GMP indicating a successful listing ahead. Investors are keenly watching this IPO, especially with the backing of influential figures like Rekha Jhunjhunwala. As the subscription period comes to a close, all eyes will be on the final allotment results and the subsequent listing on December 19.

FAQs

1. What is the current grey market premium (GMP) for the IKS IPO?

The current GMP for the IKS IPO is ₹405 per share, suggesting a potential listing price of ₹1,734 per share, which indicates a possible gain of 30.47% over the upper price band.

2. When will the IKS IPO shares be listed?

The shares of Inventurus Knowledge Solutions are expected to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on December 19, 2024, with allotments finalized by December 17.
In summary, the IKS IPO presents a compelling investment opportunity, backed by strong financial performance and significant market interest. Investors are encouraged to stay informed as the listing date approaches.